Articles by Keyword for

  According to researchers at the University of California Medical Center, and published in the March issue of Internal Medicine, screening for breast cancer every two years is preferrable to yearly screens when doing mammograms. This was based on a study of 900,000 women. It appears that this applies to women from the age of 50-94. Mammograms picked...

  The FDA published information in Journal Watch in June of 2011 that is packed with presumptive and incorrect information about breast thermography and they have to know it! Breast thermography was approved in 1982 as an adjunct to mammography to evaluate for breast cancer. In 2004 the FDA rejected breast thermography as a stand alone test for breast...

This is a PowerPoint presentation on why doctors should expand the boundaries of breast cancer screening by including breast thermography. The FDA approved this test in 1982 as an adjunct to mammography. Because it adds important information about the physiology of how breast cancers behave rather than just their anatomy, so it adds an additional valuable way...

According to a paper presented at the December 2013 annual meeting of the Radiological Society of North America, breast tomosynthesis (a limited CT scan of the breast) is a better test than the digital mammogram because it is a more sensitive test that finds breast cancers (22% more), is it associated with a lower recall rate because of false positive tests (15%fewer),...

In a recent report on mammograms published in the New York Times, they say that most women should start breast cancer screening at age 50 not 40 according to new guidelines.  They also recommend mammograms be done every two years rather than every year. The new recommendations are aimed at reducing harm from over treatment.  The report also suggests...

  One third of cancers detected by mammography may not be life-threatening according to the November of 2012 issue of the New England Journal of Medicine. Over the past 3 decades, an estimated 1.3 million women have been over-diagnosed of breast cancer that has led to treatment for a cancer for which they did not need treatment. Many of these cancers...

A novel new test is described that has not yet come into clinical practice that takes up a radioactive dye that puts out gamma rays. It is accurate but obviously has dangers related to radiation exposure. This is a potential way of screening women with dense breasts (fibrocystic breasts). Mammograms are not either an accurate or sensitive test in women with...

The conclusion of a 25 year prospective study published in the British Medical Journal in February of 2014 was that screening mammograms not only do not save lives but also lead to a 22% over-diagnosis that leads to unnecessary testing and treatment in women between the ages of 50 and 69.  After all these years of policy set by governments, research...